Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ATM |
| Variant | L2077I |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | ATM L2077I lies within the FAT domain of the Atm protein (UniProt.org). L2077I has been identified in sequencing studies (PMID: 22810696, PMID: 34954471), but has not been biochemically characterized and therefore, its effect on Atm protein function is unknown (PubMed, Jun 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
ATM mutant ATM L2077I |
| Transcript | NM_000051.4 |
| gDNA | chr11:g.108317403C>A |
| cDNA | c.6229C>A |
| Protein | p.L2077I |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_005271562.5 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542840.3 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_047426978.1 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542842.3 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| NM_000051.4 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| NM_000051 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_006718843 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| NM_001351834.2 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_005271562.6 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542840 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542843 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_005271561 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017790 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_006718843.4 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_006718843.5 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542843.3 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| NM_000051.3 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017790.3 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_005271562 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| NM_001351834.1 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542842.4 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542842 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542843.2 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017789 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_047426975.1 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017791 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_047426977.1 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017789.2 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017790.2 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_047426979.1 | chr11:g.108320000C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_011542840.4 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_047426976.1 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| XM_017017791.1 | chr11:g.108317403C>A | c.6229C>A | p.L2077I | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|